BioCurity Pharmaceuticals is a biopharmaceutical company developing drugs to prevent side effects of radiation therapy for cancer patients.
BioCurity Pharmaceuticals has raised $75K in total funding. The most recent round was Seed. The last funding was announced in April 2022.
BioCurity Pharmaceuticals is headquartered in Jupiter, United States.
BioCurity Pharmaceuticals is a biopharmaceutical company developing drugs to prevent side effects of radiation therapy for cancer patients.
BioCurity Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCurity Pharmaceuticals — Funding & Investors." VCBacked, April 8, 2022, https://www.vcbacked.co/company/biocurity-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2022). BioCurity Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biocurity-pharmaceuticals
{{cite web |title=BioCurity Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/biocurity-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated